Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cholestech/Abbott

This article was originally published in The Gray Sheet

Executive Summary

Cholestech GDX system will be distributed globally by Abbott to physician offices and hospital-based customers under an agreement signed July 24. GDX, which measures glycated hemoglobin rates, provides an average glucose level from the previous 90 days and offers an immediate risk assessment of diabetes. For the first quarter ended June 28, Cholestech sales were off 6% to $11.6 mil., while earnings rose 13% to $1.4 mil...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT016923

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel